TransMedics Group, Inc. last reported quarterly results on Aug 4, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $189.9 million (+20.7% year over year) and diluted EPS of $0.41. It usually reports 29–55 days after a quarter ends. Based on that pattern, the next release is estimated for around Oct 28, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Oct 29, 2025. The company has not filed these results with the SEC yet. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 29–55 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 4, 2026
35 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
190
+20.7%
|
15
-57.9%
|
0.41
-55.4%
|
|
May 5, 2026
35 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
174
+21.2%
|
7
-71.5%
|
0.20
-71.4%
|
|
Feb 24, 2026
55 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
161
+32.2%
|
105
+1436.9%
|
2.57
+1222.2%
|
|
Oct 29, 2025
29 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
144
+32.2%
|
24
+476.8%
|
0.66
+450.0%
|
|
Jul 30, 2025
30 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
157
+37.7%
|
35
+186.3%
|
0.92
+162.9%
|
|
May 8, 2025
38 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
144
+48.2%
|
26
+110.6%
|
0.70
+100.0%
|
|
Feb 27, 2025
58 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
122
+49.8%
|
7
+70.1%
|
0.19
+57.7%
|
|
Oct 28, 2024
28 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
109
+63.7%
|
4
+116.6%
|
0.12
+115.4%
|
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- TMDX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Andover, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1756262
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.